Sign in

Lost your password?
(close)
written on 14.08.2020

Asia-Pacific Pharma Data by Country Report 2020

main_img

HCLS Review Asia-Pacific Data by Country is an extensive compilation of the latest country-specific data on economies, healthcare, pharmaceutical industries, and R&D in some of the region’s most dynamic markets.

 

Asia-Pacific is a rapidly developing and extremely diverse region, spanning both markets at the cutting-edge of innovation and technology as well as emerging economies. The USD 959 billion Asia-Pacific market is third behind only Europe and North America in terms of global importance and stands to grow even further in the coming years, especially in developing countries.

 

This new 38-page report contains data from Australia, Hong Kong SAR, Japan, PR China, South Korea, and Taiwan and is an invaluable resource for anyone looking for up-to-date statistics and trends on these key geographies.

 

Healthcare systems and apparatus in Asia have hit the headlines in recent months thanks to their comparatively competent handling of the COVID-19 pandemic. This, coupled with positive business winds, including an uptick in the number of companies choosing to IPO in Asia despite the pandemic, shows the true dynamism of the region and signals its increasing global significance.

We use cookies to ensure that we give you the best experience on our site. For more info click here